AKRO
Price
$33.44
Change
-$1.01 (-2.93%)
Updated
Nov 11, 03:22 PM (EDT)
122 days until earnings call
GLSI
Price
$13.67
Change
-$0.72 (-5.00%)
Updated
Nov 11, 04:46 PM (EDT)
Earnings call today
Ad is loading...

AKRO vs GLSI

Header iconAKRO vs GLSI Comparison
Open Charts AKRO vs GLSIBanner chart's image
Akero Therapeutics
Price$33.44
Change-$1.01 (-2.93%)
Volume$400
CapitalizationN/A
Greenwich LifeSciences
Price$13.67
Change-$0.72 (-5.00%)
Volume$100
CapitalizationN/A
View a ticker or compare two or three
AKRO vs GLSI Comparison Chart
Loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
AKRO vs. GLSI commentary
Nov 11, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKRO is a Hold and GLSI is a Hold.

COMPARISON
Comparison
Nov 11, 2024
Stock price -- (AKRO: $34.45 vs. GLSI: $14.39)
Brand notoriety: AKRO and GLSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKRO: 157% vs. GLSI: 57%
Market capitalization -- AKRO: $2.39B vs. GLSI: $190.6M
AKRO [@Biotechnology] is valued at $2.39B. GLSI’s [@Biotechnology] market capitalization is $190.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $467.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKRO’s FA Score shows that 0 FA rating(s) are green whileGLSI’s FA Score has 0 green FA rating(s).

  • AKRO’s FA Score: 0 green, 5 red.
  • GLSI’s FA Score: 0 green, 5 red.
According to our system of comparison, AKRO is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKRO’s TA Score shows that 4 TA indicator(s) are bullish while GLSI’s TA Score has 4 bullish TA indicator(s).

  • AKRO’s TA Score: 4 bullish, 4 bearish.
  • GLSI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AKRO is a better buy in the short-term than GLSI.

Price Growth

AKRO (@Biotechnology) experienced а +6.56% price change this week, while GLSI (@Biotechnology) price change was +7.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.45%. For the same industry, the average monthly price growth was +13.33%, and the average quarterly price growth was +9.34%.

Reported Earning Dates

AKRO is expected to report earnings on Mar 13, 2025.

GLSI is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (+3.45% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKRO($2.39B) has a higher market cap than GLSI($191M). AKRO YTD gains are higher at: 47.537 vs. GLSI (36.787). GLSI has higher annual earnings (EBITDA): -10.53M vs. AKRO (-200.16M). AKRO has more cash in the bank: 760M vs. GLSI (7.23M). AKRO (0) and GLSI (0) have equivalent revenues.
AKROGLSIAKRO / GLSI
Capitalization2.39B191M1,252%
EBITDA-200.16M-10.53M1,900%
Gain YTD47.53736.787129%
P/E RatioN/AN/A-
Revenue00-
Total Cash760M7.23M10,519%
Total Debt36.3MN/A-
TECHNICAL ANALYSIS
Technical Analysis
AKROGLSI
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
87%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 6 days ago
75%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 8 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
86%
View a ticker or compare two or three
Ad is loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSMEX27.530.31
+1.14%
Carillon Scout Mid Cap A
WDIIX14.080.06
+0.43%
Wilmington Enhanced Div Inc Strat I
VWINX26.280.07
+0.27%
Vanguard Wellesley® Income Inv
OBIOX19.12-0.13
-0.68%
Oberweis International Opps Inv
CWVCX19.42-0.19
-0.97%
Calvert International Equity C

AKRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKRO has been loosely correlated with ETNB. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if AKRO jumps, then ETNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKRO
1D Price
Change %
AKRO100%
-1.20%
ETNB - AKRO
64%
Loosely correlated
+4.92%
VTYX - AKRO
51%
Loosely correlated
-1.79%
BEAM - AKRO
48%
Loosely correlated
+3.68%
DNLI - AKRO
46%
Loosely correlated
+5.91%
CRSP - AKRO
46%
Loosely correlated
-0.50%
More

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with ORMP. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
+4.20%
ORMP - GLSI
35%
Loosely correlated
-2.94%
ETNB - GLSI
33%
Poorly correlated
+4.92%
SCPH - GLSI
32%
Poorly correlated
-2.66%
SAGE - GLSI
31%
Poorly correlated
-0.16%
DNLI - GLSI
30%
Poorly correlated
+5.91%
More